Skip to main content

#151069

Anti-AP2 (a&b) [A6/2/2]

Cat. #151069

Anti-AP2 (a&b) [A6/2/2]

Cat. #: 151069

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: Activating Protein 2 (AP-2) alpha and beta forms.

Class: Monoclonal

Application: ELISA ; FACS ; IHC ; IF ; RIA ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Helen Hurst

Institute: Queen Mary University of London

Tool Details
Target Details
Applications
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-AP2 (a&b) [A6/2/2]
  • Research fields: Cancer;Tissue-specific biology;Genetics
  • Clone: A6/2/2
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; FACS ; IHC ; IF ; RIA ; WB
  • Description: AP-2 is a family of developmentally regulated transcription factors which also play a role in breast cancer and melanoma. AP-2?Ÿ may be important in cardiac and kidney development. The AP-2 transcription factors form the OB2 complex that has been shown to up-regulate c-erb-B2 transcription.
  • Immunogen: Peptide to C-Terminal of AP-2 Alpha coupled to KLH. PNSHTDNNAKSSDKEEKHRK
  • Isotype: IgG1
  • Myeloma used: NS0
  • Recommended controls: Raji cells or breast carcinomas.

Target Details

  • Target: Activating Protein 2 (AP-2) alpha and beta forms.
  • Tissue cell line specificity: Raji cells or breast carcinomas.
  • Target background: AP-2 is a family of developmentally regulated transcription factors which also play a role in breast cancer and melanoma. AP-2? may be important in cardiac and kidney development. The AP-2 transcription factors form the OB2 complex that has been shown to up-regulate c-erb-B2 transcription.

Applications

  • Application: ELISA ; FACS ; IHC ; IF ; RIA ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

Related Tools

  • Related tools: Anti-cMyc [9E10]

References

  • Yang et al. 2005. J Am Soc Nephrol. 16(10):2890-6. PMID: 16107581.
  • Redistribution of myosin VI from top to base of proximal tubule microvilli during acute hypertension.
  • Gee et al. 1999. J Pathol. 189(4):514-20. PMID: 10629551.
  • Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer.
  • Batsch et al. 1998. Mol Cell Biol. 18(7):3647-58. PMID: 9632747.
  • RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.